Indeed, inhibition of the protease activity of MALT1 with a peptide inhibitor or small molecule drugs efficiently inhibits the growth of cells derived from ABC DLBCL in vitro and in xenograft models [26]–[29]. The gene discussed is MALT1; the disease is diffuse large B-cell lymphoma.